The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
‘One button push’ fully automated PSMA PET quantification: Correlation with progression free and overall survival in patients undergoing [177Lu] Lu PSMA therapy for metastatic castrate resistant prostate cancer.
 
Louise Emmett
Consulting or Advisory Role - Advancell; Astellas Pharma; Clarity Pharmaceuticals; Novartis
Speakers' Bureau - Astellas Pharma (Inst); Janssen Oncology; mundipharma; Novartis
Research Funding - Clarity Pharma (Inst); Novartis (Inst); PCF (Inst)
Travel, Accommodations, Expenses - Advancell
 
Alex Zheng
Stock and Other Ownership Interests - Clarity Pharmaceuticals; Fisher and Paykel; Healius Limited; Sigma Healthcare
 
Charlie Jin
Stock and Other Ownership Interests - Invesco QQQ Trust
 
Nathan Papa
No Relationships to Disclose
 
Sobia Khan
No Relationships to Disclose
 
Narjess Ayati
No Relationships to Disclose
 
Timothy Susman
Employment - MIM Software
 
Ken Ngai
Employment - MIM Software; MIM Software, A GE HealthCare Company
 
Aaron Nelson
Employment - MIM Software Inc.; MIM Software, A GE HealthCare Company
Leadership - MIM Software Inc.; MIM Software, A GE HealthCare Company
Stock and Other Ownership Interests - MIM Software Inc.
 
Shikha Sharma
No Relationships to Disclose
 
Rahul Anand
Stock and Other Ownership Interests - Clarity Pharmaceuticals
 
Nikeith John
No Relationships to Disclose
 
Megan Crumbaker
Honoraria - Bayer; Merck
Consulting or Advisory Role - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - MSD Oncology
 
Andrew Nguyen
No Relationships to Disclose
 
Ken Herrmann
Leadership - Aktis Oncology; Pharma15
Stock and Other Ownership Interests - AdvanCell; Aktis Oncology; Convergent Therapeutics; SOFIE
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bain Capital; Bayer; Boston Scientific; BTG; Debiopharm Group; Fusion Pharmaceuticals; GE Healthcare; Immedica; IPSEN; ITG (Inst); Janssen Oncology; Molecular Partners; Novartis; Radiopharm Theranostics; ROTOP Pharmaka (Inst); Siemens Healthineers; Telix Pharmaceuticals